Viability of Plasmodium falciparum parasites in human plasma under different storage conditions

Anna Lavrentieva1, Miranda S Oakley1, Clifford T H Hayashi1

  • 1Office of Blood Research and Review, Center for Biologics Evaluation and Review, Food and Drug Administration, Silver Spring, Maryland, USA.

Vox Sanguinis
|December 12, 2024
PubMed
Abstract

Insights

Plasmodium falciparum parasites can survive in human plasma for extended periods, especially when frozen at -80°C for up to 176 days. This finding highlights the risk of transfusion-transmitted malaria from plasma components.

Area of Science:

  • Transfusion Medicine
  • Infectious Diseases
  • Parasitology

Background:

  • Malaria risk deferral policies are crucial for preventing transfusion-transmitted malaria.
  • These policies apply to all transfusable components, including plasma.
  • The viability of Plasmodium falciparum in stored human plasma is not well-documented.

Purpose of the Study:

  • To investigate the viability of Plasmodium falciparum parasites in human plasma under various storage conditions.
  • To assess the risk of transfusion-transmitted malaria associated with plasma components.

Main Methods:

  • Human plasma was spiked with Plasmodium falciparum-infected red blood cells.
  • Parasite viability was determined after storage at room temperature (22°C), refrigeration (4°C), and frozen conditions (-20°C and -80°C).

Main Results:

  • Parasites remained viable at 22°C for up to 7 days.
  • Viability at 4°C was observed for 1-3 days, and at -20°C for 1 day.
  • At -80°C, parasites remained viable for up to 176 days, indicating a cryopreserving effect.

Conclusions:

  • Plasmodium falciparum can survive in human plasma under various storage temperatures.
  • Extended parasite viability at -80°C poses a significant risk for transfusion-transmitted malaria.
  • Current storage conditions may not fully mitigate the risk of malaria transmission via plasma components.